SCHEMBL3734858

SCHEMBL3734858

NC(=O)c1sc(-n2cnc3ccncc32)cc1OCc1cccc(C(F)(F)F)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 20/20 0.61
MAP4K4 O95819 2/20 0.58
CSF1R P07333 2/20 0.58
KDR P35968 2/20 0.58
NEK2 P51955 2/20 0.58
LIMK1 P53667 2/20 0.58
STK3 Q13188 2/20 0.58
DYRK1A Q13627 2/20 0.58
BRSK1 Q8TDC3 2/20 0.58
SLK Q9H2G2 2/20 0.58
PLK3 Q9H4B4 2/20 0.58
CLK4 Q9HAZ1 2/20 0.58
MAP4K5 Q9Y4K4 2/20 0.58
PIM1 P11309 1/20 0.58
CAMK2B Q13554 1/20 0.58
CAMK2G Q13555 1/20 0.58
CAMK2D Q13557 1/20 0.58
CAMK1 Q14012 1/20 0.58
PKN2 Q16513 1/20 0.58
HIPK4 Q8NE63 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3736022 0.93 PLK1 (0.61) PLK1MAP4K4CSF1RKDRNEK2
SCHEMBL3729461 0.91 PLK1 (0.64) PLK1MAP4K4CSF1RKDRNEK2
SCHEMBL3734993 0.90 PLK1 (0.52) PLK1MAP4K4CSF1RKDRNEK2
SCHEMBL3734905 0.84 PLK1 (0.82) PLK1MAP4K4CSF1RKDRNEK2
SCHEMBL3745124 0.83 PLK1 (0.64) PLK1MAP4K4CSF1RKDRNEK2
SCHEMBL3732566 0.83 PLK1 (0.52) PLK1MAP4K4CSF1RKDRNEK2
SCHEMBL3745331 0.81 PLK1 (0.65) PLK1MAP4K4CSF1RKDRNEK2
SCHEMBL3736013 0.81 PLK1 (0.73) PLK1MAP4K4CSF1RKDRNEK2
SCHEMBL3737811 0.81 PLK1 (0.81) PLK1MAP4K4CSF1RKDRNEK2
SCHEMBL3739454 0.81 PLK1 (0.66) PLK1MAP4K4CSF1RKDRNEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273890-B2 Thiophene-imidazopyridines 4SC AG (DE) 2012-09-25 US disclosed
US-20100278833-A1 THIOPHENE-IMIDAZOPYRIDINES 4SC AG (DE) 2010-11-04 US disclosed
EP-2017277-A1 Thiophene-imidazopyridines 4SC AG (DE) 2009-01-21 EP disclosed
WO-2009003911-A1 THIOPHENE-IMIDAZOPYRIDINES 4SC AG (DE) 2009-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100278833-A1 THIOPHENE-IMIDAZOPYRIDINES PIKFYVE, PIP4K2B, PIP5K1B PLK1 642/4885MAP4K4 386/4885CSF1R 2699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.